Kleanthis G. Xanthopoulos

2008 - Ionis Pharmaceuticals

In 2008, Kleanthis G. Xanthopoulos earned a total compensation of $832.6K as Chief Executive Officer of Regulus Therapeutics Inc at Ionis Pharmaceuticals, a 225% increase compared to previous year.

Compensation breakdown

Bonus$223,080
Option Awards$194,268
Salary$400,000
Other$15,208
Total$832,556

Xanthopoulos received $400K in salary, accounting for 48% of the total pay in 2008.

Xanthopoulos also received $223.1K in bonus, $194.3K in option awards and $15.2K in other compensation.

Rankings

In 2008, Kleanthis G. Xanthopoulos' compensation ranked 4,955th out of 9,135 executives tracked by ExecPay. In other words, Xanthopoulos earned more than 45.8% of executives.

ClassificationRankingPercentile
All
4,955
out of 9,135
46th
Division
Manufacturing
1,788
out of 3,436
48th
Major group
Chemicals And Allied Products
357
out of 815
56th
Industry group
Drugs
216
out of 597
64th
Industry
Pharmaceutical Preparations
158
out of 408
61st
Source: SEC filing on April 17, 2009.

Xanthopoulos' colleagues

We found four more compensation records of executives who worked with Kleanthis G. Xanthopoulos at Ionis Pharmaceuticals in 2008.

2008

Stanley Crooke

Ionis Pharmaceuticals

Chief Executive Officer

2008

B Parshall

Ionis Pharmaceuticals

Chief Financial Officer

2008

C Bennett

Ionis Pharmaceuticals

Senior Vice President, Antisense Research

2008

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

You may also like